328 related articles for article (PubMed ID: 27307735)
21. Hyaluronic acid embedded cellulose acetate phthlate core/shell nanoparticulate carrier of 5-fluorouracil.
Garg A; Rai G; Lodhi S; Jain AP; Yadav AK
Int J Biol Macromol; 2016 Jun; 87():449-59. PubMed ID: 26955748
[TBL] [Abstract][Full Text] [Related]
22. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
[TBL] [Abstract][Full Text] [Related]
23. Desosomes and desimicelles - a novel vesicular and micellar system for enhanced oral delivery of poorly soluble drug: Optimization of in vitro characteristics and in vivo performance.
Said AR; Asaad GF; Shabana ME; Sayed AS; Elfeky DH; Mohamed Ali H; Adel Abdelfattah A; M El-Husseiny H; El-Dakroury WA
Eur J Pharm Biopharm; 2024 Jul; 200():114324. PubMed ID: 38759898
[TBL] [Abstract][Full Text] [Related]
24. Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.
Zhao L; Mustapha O; Shafique S; Jamshaid T; Din FU; Mehmood Y; Anwer K; Yousafi QUA; Hussain T; Khan IU; Ghori MU; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():8819-8828. PubMed ID: 33204090
[TBL] [Abstract][Full Text] [Related]
25. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
26. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
27. Formulation of two-drug controlled release non-biodegradable microparticles for potential treatment of muscles pain and spasm and their simultaneous spectrophotometeric estimation.
Khan SA; Ahmad M; Murtaza G; Aamir MN; Akhtar N; Kousar R
Acta Pol Pharm; 2010; 67(3):299-306. PubMed ID: 20524433
[TBL] [Abstract][Full Text] [Related]
28. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.
Pireddu R; Caddeo C; Valenti D; Marongiu F; Scano A; Ennas G; Lai F; Fadda AM; Sinico C
Colloids Surf B Biointerfaces; 2016 Jul; 143():64-70. PubMed ID: 26998867
[TBL] [Abstract][Full Text] [Related]
29. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
[TBL] [Abstract][Full Text] [Related]
30. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
Silva CO; Rijo P; Molpeceres J; Figueiredo IV; Ascensão L; Fernandes AS; Roberto A; Reis CP
Int J Pharm; 2015 Sep; 493(1-2):271-84. PubMed ID: 26222745
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
Kenechukwu FC; Dias ML; Ricci-Júnior E
Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
[TBL] [Abstract][Full Text] [Related]
32. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
33. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
34. Permeation of piroxicam from the poloxamer gels.
Shin SC; Cho CW; Choi HK
Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
[TBL] [Abstract][Full Text] [Related]
35. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
36. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
37. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
39. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
[TBL] [Abstract][Full Text] [Related]
40. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
